Yesterday | PE Hub
Teralys Capital, Eli Lilly and Others Back TVM Life Science Ventures VII
Teralys Capital has invested $65 million in TVM Life Science Ventures VII which has closed on $150 million.
Eli Lilly's Cialis faces faster-acting competition
A Vivus Inc. pill that is supposed to provide erections within 15 minutes, about half the time or less than Eli Lilly and Co.'s Cialis or Pfizer Inc.'s Viagra, has received U.S. regulatory approval.